Skip to main content
Erschienen in: Reactions Weekly 1/2023

01.11.2023 | Case report

Rituximab/tacrolimus

Thrombotic microangiopathy, acute kidney injury and allergy: case report

Erschienen in: Reactions Weekly | Ausgabe 1/2023

Einloggen, um Zugang zu erhalten

Excerpt

Author Information
An event is serious (based on the ICH definition) when the patient outcome is:
  • * death
  • * life-threatening
  • * hospitalisation
  • * disability
  • * congenital anomaly
  • * other medically important event
Literatur
Zurück zum Zitat Ibrahim MM, et al. Tacrolimus-Induced Thrombotic Microangiopathy (TMA) Complicated by Anamnestic Donor-Specific Antibodies Post-Kidney Transplantation. American Journal of Transplantation 23 (Suppl. 1): S629 abstr. A37, No. 6, Jun 2023. Available from: URL: http://doi.org/10.1016/j.ajt.2023.05.014 [abstract] Ibrahim MM, et al. Tacrolimus-Induced Thrombotic Microangiopathy (TMA) Complicated by Anamnestic Donor-Specific Antibodies Post-Kidney Transplantation. American Journal of Transplantation 23 (Suppl. 1): S629 abstr. A37, No. 6, Jun 2023. Available from: URL: http://​doi.​org/​10.​1016/​j.​ajt.​2023.​05.​014 [abstract]
Metadaten
Titel
Rituximab/tacrolimus
Thrombotic microangiopathy, acute kidney injury and allergy: case report
Publikationsdatum
01.11.2023
Verlag
Springer International Publishing
Erschienen in
Reactions Weekly / Ausgabe 1/2023
Print ISSN: 0114-9954
Elektronische ISSN: 1179-2051
DOI
https://doi.org/10.1007/s40278-023-49320-0

Weitere Artikel der Ausgabe 1/2023

Reactions Weekly 1/2023 Zur Ausgabe

Case report

Loperamide

Case report

Linezolid

Case report

Alendronic-acid